Series D - Aldagen
Investment Firm
Overview
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.
Announced Date
Apr 23, 2008
Funding Type
Series D
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Aldagen raised $18400000 on 2008-04-23 in Series D
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 23, 2011 |  Debt Financing - Aldagen | - | 1.1M | |
| Jan 13, 2012 | Debt Financing - Aldagen | - | 585.0K | |
| Sep 01, 2007 | Series C - Aldagen | 4 | - | 9.0M |
| Apr 23, 2008 | Series D - Aldagen | 4 | - | 18.4M |
Recent Activity
There is no recent news or activity for this profile.